Application no. and date | 21758144.6 (espacenet) (Federated) (European Patent Register), 20210806 | Patent/reg. no. and date | DK/EP 3953330, 20221012 | Publication date | 20220216 | Priority no. and date | US 202063073982 P, 20200903, US 202163143435 P, 20210129, US 202163170158 P, 20210402, US 202163194241 P, 20210528 | EP pub. no. and date |
EP 3953330 20220216 | Effective date | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US | Applicant ref. no. | V449241DK00 | Inventor | YANG, Xiaojing,
Groton, Connecticut 06340, US, OWEN, Dafydd Rhys,
Cambridge, Massachusetts 02139, US, PETTERSSON, Martin Youngjin,
Littleton, Massachusetts 01460, US, REESE, Matthew Richard,
Groton, Connecticut 06340, US, SAMMONS, Matthew Forrest,
Cambridge, Massachusetts 02139, US, TUTTLE, Jamison Bryce,
Cambridge, Massachusetts 02139, US, VERHOEST, Patrick Robert,
Cambridge, Massachusetts 02139, US, WEI, Liuqing,
Groton, Connecticut 06340, US, YANG, Qingyi,
Cambridge, Massachusetts 02139, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/4015 (2006.01) , A61K 31/4025 (2006.01) , A61P 31/14 (2006.01) , C07D 207/267 (2006.01) , C07D 401/12 (2006.01) , C07D 403/12 (2006.01) , C07D 403/14 (2006.01) , C07D 497/04 (2006.01) | Title | Nitrilholdige forbindelser, der kan anvendes som antivirale midler til behandlingen af en coronavirusinfektion | Int. application no. | IB2021057281 | Int. publication no. | WO2021250648 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|